• Media type: E-Article
  • Title: Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020) : Statement of the Austrian Society of Pneumology (ASP) : Statement of the Austrian Society of Pneumology (ASP)
  • Contributor: Flick, Holger; Arns, Britt-Madelaine; Bolitschek, Josef; Bucher, Brigitte; Cima, Katharina; Gingrich, Elisabeth; Handzhiev, Sabin; Hochmair, Maximilian; Horak, Fritz; Idzko, Marco; Jaksch, Peter; Kovacs, Gabor; Kropfmüller, Roland; Lamprecht, Bernd; Löffler-Ragg, Judith; Meilinger, Michael; Olschewski, Horst; Pfleger, Andreas; Puchner, Bernhard; Puelacher, Christoph; Prior, Christian; Rodriguez, Patricia; Salzer, Helmut; Schenk, Peter; [...]
  • imprint: Springer Science and Business Media LLC, 2020
  • Published in: Wiener klinische Wochenschrift
  • Language: English
  • DOI: 10.1007/s00508-020-01691-0
  • ISSN: 0043-5325; 1613-7671
  • Keywords: General Medicine
  • Origination:
  • Footnote:
  • Description: <jats:title>Summary</jats:title><jats:p>The coronavirus disease 2019 (COVID-19) pandemic is currently a challenge worldwide. In Austria, a crisis within the healthcare system has so far been prevented. The treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV‑2 infections, should continue to be based on evidence-based CAP guidelines during the pandemic; however, COVID-19 specific adjustments are useful. The treatment of patients with chronic lung diseases has to be adapted during the pandemic but must still be guaranteed.</jats:p>